ABL301

· ABL Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABL301, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants [Phase 1]

See pricing